InvaGen Pharmaceuticals, Inc.

5 articles with InvaGen Pharmaceuticals, Inc.

• InvaGen (a Cipla Subsidiary) Receives Final Approval for Generic Version of Pfizer's Lyrica® (Pregabalin Capsules, 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg)

  7/22/2019

  InvaGen Pharmaceuticals, Inc., a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited announced the receipt of final approval for its Abbreviated New Drug Application for Pregabalin Capsules, 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg and 300mg from the United States Food and Drug Administration.

• PuraCap Pharmaceutical Seeks Damages From InvaGen Pharmaceuticals, Inc. For Contract Violation

  10/26/2015

• InvaGen, Inc. Looks to Expand in New York; Will Create and Retain Nearly 700 Jobs

  10/19/2011

• Perrigo Company To Market Terbinafine Hydrochloride Tablets

  8/7/2006

• Andrx Corporation Announces Commercialization Agreement With InvaGen, Inc.

  1/23/2006